Introduction {#sec1-1}
============

*Karnasrava* is a disease mentioned by *Acharya Sushruta* in the chapter of *Karnaroga Vigyaniya* under twenty eight *Karnarogas*.\[[@ref1]\] *Acharya Charaka* included *Karnasrava* as a symptom under the four types of *Karnarogas* due to vitiation of different *Dosha*.\[[@ref2]\] *Karnasrava* (discharge) is one of symptom of otomycosis. In *Vranasrava Vigyaniya Adhyaya*, *Acharya Sushruta* has described many types of *Srava*. Out of them *Twakagata* and *Mamsagata Srava* is in parlance with modern otomycosis.\[[@ref3]\]

Otomycosis is a type of otitis externa occuring due to fungal infection. In general population, the prevalence of otomycosis is 5.2% all over world and in India 9.00% according to American academy of otolaryngology. Further 5-25% of otitis externa cases are due to otomycosis. The 90% of fungal infections involve Aspergillus species and the rest Candida species.\[[@ref4]\]

The general line of treatment of *Karnasraava* includes *Shirovirechana, Dhupana, Karnapurana, Pramaarjana, Dhaavana, Prakshaalana* etc.\[[@ref5]\] In otomycosis, frequent cleaning of external auditory canal either by suction, evacuation, or by syringing, followed by moping are advised which are very similar to treatment of *Karnasrava*. Further topical medications are applied as disinfectant, anti-inflammatory, and antifungal.\[[@ref6]\] For this study, clotrimazole has been selected as standard control. But it is having side effects like burning sensation, stinging sensation, etc. The treatment of this particular disease has never been satisfactory and therefore, a number of treatments were advised to relive this condition. So, to overcome above problems there is a need to find cheaper and easily available Ayurvedic medicine. In the present study, *Arka Taila* was selected as a local therapeutic procedure for *Karnapurana*.

Aims and objectives {#sec2-1}
-------------------

To assess the efficacy of *Arka Taila* in the management of *Karnasrava* (Otomycosis)To compare the efficacy of *Arka Taila* with clotrimazole in the management of *Karnasrava* (Otomycosis).

Materials and Methods {#sec1-2}
=====================

Selection of patients {#sec2-2}
---------------------

The patients fulfilling inclusion criteria, attending the O.P.D. of Department of Shalakya, I.P.G.T and R.A. Hospital, Gujarat Ayurved University, Jamnagar were selected irrespective of age, sex, religion, race, occupation, etc.A detailed proforma was prepared incorporating Ayurvedic and Modern points. Trial drug was prepared in the Department of R.S. and B.K., I.P.G.T. and R.A., Jamnagar.

Inclusion criteria {#sec2-3}
------------------

The selection of patients was done on the basis of signs and symptoms of *Karnasrava* (Otomycosis) described as per Ayurvedic and modern medical science.

Exclusion criteria {#sec2-4}
------------------

Patients suffering from any debilitating diseases like diabetes, T.B., etc. and with other aural pathology e.g. Chronic suppurative otitis media (CSOM), acute suppurative otitis media (ASOM), perforation of tympanic membrane, etc. were excluded from the study.

Sampling method {#sec2-5}
---------------

Random sampling method

Assessment criteria {#sec2-6}
-------------------

The efficacy of the therapy was assessed on the basis of subjective criteria, for statistical analysis scoring was designed according to the severity of symptoms.

Overall effect of therapy {#sec2-7}
-------------------------

Cured: 100% relief in subjective and objective symptoms.Marked improvement: 76-99% relief in subjective and objective symptoms.Moderate improvement: 51-75% relief in subjective and objective symptoms.Mild improvement: 26-50% relief in subjective and objective symptoms.Unchanged: Upto 25% relief in subjective and objective symptoms.

Group, dose and duration {#sec2-8}
------------------------

Group-A: Patients were treated with *Arka Taila* for *Karnapurana* (approx. 10-15 ml) for hundred *Matra* for 15 days with an interval of 5 days.

Group-B: Patients were treated with Clotrimazole eardrops. Two drops thrice daily for 15 days.

Follow-up of the treatment {#sec2-9}
--------------------------

Patients were asked to attend the O.P.D. for 1 month after completion of therapy for the follow up.

Statistical test {#sec2-10}
----------------

The data obtained on the basis of observations was subjected to statistical analysis in terms of mean, standard deviation error by applying the unpaired '*t*' test. The results were interpreted at the level of *P*\<0.001 as highly significant, *P*\<0.05 or *P*\<0.01 as significant, and *P*\>0.01 as insignificant.

Preparation of *Arka Taila* {#sec2-11}
---------------------------

*Arka Taila* contains only three drugs viz. *Arka Patra* (*Calotropis procera*), *Haridra* (*Curcuma longa*) and *Sarshapa Taila Brassica campestris*).\[[@ref7]\] *Arka Taila* was prepared by general method of preparation of *Taila Kalpana* till the *Kharapaka* stage.\[[@ref8]\] *Arka Taila* has *Katu* and *Tikta Rasa*, *Ruksha*, *Laghu*, *Tikshna Guna*, *Ushna Veerya*, *Katu Vipaka*, and *Kapha-Vatashamaka* properties.

Design of study {#sec2-12}
---------------

The study was conducted on 28 diagnosed cases of *Karnasrava*. Patients were selected from OPD, Department of Shalakya, I.P.G.T. and R.A., G.A.U., Jamnagar. Out of which 02 patients discontinued the treatment. Remaining 26 patients completed the study.

Ethical clearance {#sec2-13}
-----------------

The study was cleared by the institutional ethics committee. Written consent from each patient willing to participate before starting the study was taken. For those patients who were unable to read or write consent of their relative was taken. Patients were free to withdraw their name from the study at any time without giving any reason.

Observations and Results {#sec1-3}
========================

In the present study, 21.42% patients belong to the age group of 51-60 years, 57.15% patients were male, 32.14% patients were house wives, and 82.14% patients were from middle class.

Maximum number of patients, i.e. 39.29%, were found having *Nidana* of water entry in ear followed by 28.57% having unknown etiology, 25.00% patients having *Nidana* of *Pratishyaya*, 17.87% patients were found having *Nidana* of scratching of ear, and 3.57% patients had history of ear scratching along with water entry into the ear and *Avashyaya*.

Majority of patients, i.e. 53.57%, were of *Vata Kapha Prakriti*, 60.71% patients were of *Rajasika Manasa Prakriti*, 92.86% patients were of *Madhyama Samhanana*, *Sara*, *Satva*, *Aharashakti*, *Vyayamashakti* and *Vaya* found. 82.14% patients were having *Madhyama Satmya*. Maximum number of patients, i.e. 39.28%, were having chronicity of 6-10 days; 75.00% patients were having one ear affliction. Maximum number of patients, i.e. 85.71%, had *Karnakandu*, followed by 82.14% patients had *Karnashula* and *Karnapratinaha*, 78.57% patients had *Karnasrava*, 71.43% patients had *Badhirya*, and 57.14% patients had *Karnanada* as presenting symptom. The otoscopic signs i.e. fungal mass had been observed in maximum number of patients, i.e. 100.00% followed by 38.46% patients had tenderness and 19.23% patients had erythema.

Total effect of therapy {#sec2-14}
-----------------------

In Group-A, patients showed 90.91% relief in *Karnashula* followed by *Karnakandu* (90.00%), *Karnasrava* (88.24%), *Karnanaha* (72.72%), *Karnanada* (68.75%) and *Badhirya* (34.78%), statistically all the results were found highly significant at the level of *P*\<0.001 except *Badhirya* (\<0.01) which is significant. Patients showed 100% relief in tenderness and erythema followed by 77.27% relief in fungal mass. The results were statistically highly significant in all the signs at the level of *P*\<0.001 \[[Table 1](#T1){ref-type="table"}\].

###### 

Effect of therapy in Group-A on signs and symptoms in 13 patients of *Karnasrava* (otomycosis)

![](Ayu-32-349-g001)

In Group-B, patients showed 100.00% relief in *Karnasrava*, *Karnashula*, and *Karnanada* followed by 90.69% relief in *Karnakandu*, 81.81% relief in *Karnanaha*, and 66.66% relief in *Badhirya* \[[Table 2](#T2){ref-type="table"}\]. The results were found highly significant at the level of *P*\<0.001 in all the symptoms except *Badhirya* where it was significant at the level of *P*\<0.01. Patients showed 100% relief in tenderness and erythema. The results were statistically highly significant in all the Otoscopic signs at the level of *P*\<0.001. Patients showed 83.33% relief in fungal mass. The result was significant at the level of *P*\<0.01 \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of therapy in Group-B on signs and symptoms in 13 patients of *Karnasrava* (otomycosis)
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Overall effect of therapy {#sec2-15}
-------------------------

46.16% cure was found in Group A, while 69% cure in Group B. Over all effect of the therapy is depicted at [Figure 1](#F1){ref-type="fig"}.

![Overall effect of therapy](Ayu-32-349-g003){#F1}

Discussion {#sec1-4}
==========

*Karnasrava* is explained as a symptom and as a disease in *Ayurveda*. While describing the etiological factors of *Karnasrava*, *Aacharya* have given special emphasis to *Jalanimanjjana* and *Karnakanduyana* which is commonly found in otomycosis. In *Samprapti* of *Karnasrava*, *Aacharya Sushruta* has mentioned that *Avarana* of *Vata* by other *Dosha* is the chief culprit for initiation of the pathology.\[[@ref9]\]

By assessing the symptoms, it can be said that *Kapha Aavrita* *Vata Dosha* is responsible for the manifestation of clinical features like discharge, pain, itching, etc. of otomycosis. In otomycosis, mainly watery and purulent type of discharge is present which shows the condition of *Paka*. While removing the fungal mass, ulceration of external auditory canal is likely to happen. Considering these points otomycosis can also be treated in the line of *Dushtavrana*. Regarding *Sadhyasadhyata*, *Acharya* has mentioned that *Vrana* situated in *Twaka* and *Mamsa* and *Vrana* lies in *Karna* is *Sukhasadhya*.\[[@ref10]\] In *Uttaratantra, Acharya Sushruta* considered *Karnasrava* itself as *Sadhyaroga*.

The mode of action of the drug under trial can be understood on the basis of inherent properties of the drugs.

Rasa of all the drugs are *Katu* and *Tikta*; *Guna* are *Ruksha*, *Laghu*, *Tikshna*; *Snigdha* and *Ushna Veerya* and mainly *Kapha-Vata* *Shaamaka* properties.

With the properties of *Katu* and *Tikta Rasa*, it will encounter *Vata* and *Kapha Dosha*. The *Katu Rasa* removes obstruction, dilates the passages, and relieves *Kapha*.\[[@ref11]\]

*Tikta Rasa* induces cleanness, dryness, and keenness. With *Krimihara* and *Puyashoshanakara* properties it will help to remove ear debris, fungal mass, discharge, and reduces itching. *Tikta Rasa* contains *Shodhana* property which can help to open channels and clean the wound, ultimately leads healing process. *Ruksha Guna* is having *Shoshana Shakti* which can absorb the discharge in auditory canal and pacifies the *Kapha Dosha*. *Laghu Guna* having *Lekhana* and *Ropana* properties which can help in healing of wound. *Tikshna Guna* is *Shighrakari* which means it starts action very quickly and will encounter *Vata* and *Kapha Dosha*. Due to *Ushna Veerya* it will encounter *Vata Dosha* and *Gati* of *Vata* gets normalized (*Anulomana*). This way it will work on functional mechanism. Another benefit of *Ushna Veerya* is that it enhances local as well as general metabolism. Because of this, it will correct *Dhatuposhana Krama* and ultimately it will leads to production of *Uttama Twaka* and *Mamsa Dhatu*.

Conclusion {#sec1-5}
==========

On the basis of clinical features, otomycosis can be correlated with *Karnasrava* having predominance of *Vata* and *Kapha Dosha*. For *Karnapurana Taila* should be prepared till the stage of *Kharapaka*. *Karnapurana* is very effective local procedure in *Karnagata Roga*. Sufficient amount (approximately 10-15 drops) of *Arka Taila* should be instilled (*Karnapurana*) to get expected results. *Arka Taila* has not shown any side effect so it should be used. Both the drugs (*Arka Taila* and Clotrimazole) are equally effective to treat the disease *Karnasrava* (Otomycosis). *Arka Taila Karnapurana* for duration of 15 days (minimum 6-10 days) is sufficient for the treatment of the disease *Karnasrava* (Otomycosis), provided proper *Pathyapathya* should be followed. As *Vrana* is always present in patient of *Karnasrava*-otomycosis, *Dushtavrana Chikitsa* can be adopted in treatment of *Karnasrava*. *Shashti Upakrama* can be incorporated in treatment of *Karnasrava* (otomycosis) in further study on a larger sample.
